Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus A Seeger

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Nature Communications|November 5, 2020
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Tânia F Custódio, Hrishikesh Das, Daniel J Sheward, et al.
Nature Communications|May 22, 2025
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastomaMichal Beffinger, Linda Schellhammer, Betül Taskoparan, et al.
EMBO Reports|March 7, 2022
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistanceJustin D Walter, Melanie Scherer, Cedric A J Hutter, et al.
Microbes and Infection|September 7, 2025
ESCMID workshop: Artificial intelligence and machine learning in medical microbiology diagnosticsMariella Greutmann, Karsten Borgwardt, Sarah Brüningk, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Nature Communications|November 5, 2020
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Tânia F Custódio, Hrishikesh Das, Daniel J Sheward, et al.
Nature Communications|May 22, 2025
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastomaMichal Beffinger, Linda Schellhammer, Betül Taskoparan, et al.
EMBO Reports|March 7, 2022
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistanceJustin D Walter, Melanie Scherer, Cedric A J Hutter, et al.
Microbes and Infection|September 7, 2025
ESCMID workshop: Artificial intelligence and machine learning in medical microbiology diagnosticsMariella Greutmann, Karsten Borgwardt, Sarah Brüningk, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Pageof 8